Streetbeat News

Analyst Ratings

GEV

RBC Capital analyst Christopher Dendrinos has reiterated an Outperform rating on GE Vernova (NYSE:GEV) and maintained a price target of $262.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 1:04 pm

COHR

Coherent shares declined following a downgrade by B. Riley Securities from Buy to Neutral.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 1:04 pm

JHG

Morgan Stanley analyst Andrei Stadnik has maintained an Equal-Weight rating on Janus Henderson Group (NYSE:JHG) while raising the price target from $39 to $42.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 1:03 pm

NFLX

JP Morgan analyst Doug Anmuth maintains an Overweight rating on Netflix and raises the price target from $750 to $850.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 1:03 pm

HOMB

RBC Capital analyst Jon Arfstrom has reiterated a Sector Perform rating on Home BancShares (NYSE:HOMB) and maintained a price target of $28.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 1:03 pm

AVGO

MRVL

JPMorgan analyst Harlan Sur predicts a semiconductor up-cycle, with Broadcom and Marvell leading due to their strong positions in cloud and AI markets. The sector is expected to see positive growth into 2025, driven by demand for cloud infrastructure and custom chips. Clearing excess inventory and ongoing M&A activity are also positive factors.

Portfolio Pulse from Surbhi Jain

October 18, 2024 | 1:02 pm

AA

Morgan Stanley analyst Carlos De Alba maintains an Overweight rating on Alcoa (NYSE:AA) and raises the price target from $48 to $49.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 1:02 pm

HES

Analysts have varied opinions on Hess (NYSE:HES), with recent ratings showing a mix of bullish, indifferent, and bearish sentiments. The average 12-month price target has decreased by 4.94% to $165.0. Hess has shown strong financial performance with significant revenue growth and profitability, but its high debt-to-equity ratio raises concerns.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 1:01 pm

RAPP

Jones Trading has initiated coverage on Rapport Therapeutics with a Buy rating and set a price target of $42.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 1:01 pm

FTAI

FTAI Aviation (NASDAQ:FTAI) has received 15 analyst ratings in the last three months, with a majority being bullish. Analysts have raised their 12-month price targets, reflecting a positive outlook. Despite strong revenue growth, FTAI faces challenges with profitability and financial performance metrics.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 1:01 pm